Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma

Condition:   NK/T Cell Lymphoma Interventions:   Drug: IV Nivolumab;   Drug: IV Gemcitabine;   Drug: IV Cisplatin;   Drug: IV/PO Dexamethasone;   Drug: IV L-asparaginase Sponsors:   National Cancer Centre, Singapore;   Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials